Biovertis
Latest round
- Series B
Last raised
- Dec 2005
Total raised
- $27M
Investors
- 3
About Biovertis
Biovertis AG is a biopharmaceutical company developing small molecule drugs against proprietary microbial antigens.
Who invested in Biovertis
3 investors across 2 rounds
See all investors in Biovertis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biovertis
Who invested in Biovertis?
Biovertis has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biovertis raised?
Biovertis has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biovertis last raise money?
Biovertis's most recent round on record is a Series B, in Dec 2005.
What does Biovertis do?
Biovertis AG is a biopharmaceutical company developing small molecule drugs against proprietary microbial antigens.
Where is Biovertis headquartered?
Biovertis is headquartered in Vienna, Austria.
Which VCs invest in companies like Biovertis?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Biovertis's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Biovertis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.